These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 31916109)
1. Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease. Stock CJW; De Lauretis A; Visca D; Daccord C; Kokosi M; Kouranos V; Margaritopoulos G; George PM; Molyneaux PL; Nihtyanova S; Chua F; Maher TM; Ong V; Abraham DJ; Denton CP; Wells AU; Wain LV; Renzoni EA Clin Rheumatol; 2020 Apr; 39(4):1173-1179. PubMed ID: 31916109 [TBL] [Abstract][Full Text] [Related]
2. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis. Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887 [TBL] [Abstract][Full Text] [Related]
3. The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms. Zhao W; Yue X; Liu K; Zheng J; Huang R; Zou J; Riemekasten G; Petersen F; Yu X Rheumatol Int; 2017 Aug; 37(8):1303-1310. PubMed ID: 28434122 [TBL] [Abstract][Full Text] [Related]
4. BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Dieudé P; Wipff J; Guedj M; Ruiz B; Melchers I; Hachulla E; Riemekasten G; Diot E; Hunzelmann N; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Distler J; Amoura Z; Tarner I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y Arthritis Rheum; 2009 Nov; 60(11):3447-54. PubMed ID: 19877059 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis. Xu Y; Wang W; Tian Y; Liu J; Yang R Int J Dermatol; 2016 Apr; 55(4):408-16. PubMed ID: 26712637 [TBL] [Abstract][Full Text] [Related]
6. IRF5 polymorphism predicts prognosis in patients with systemic sclerosis. Sharif R; Mayes MD; Tan FK; Gorlova OY; Hummers LK; Shah AA; Furst DE; Khanna D; Martin J; Bossini-Castillo L; Gonzalez EB; Ying J; Draeger HT; Agarwal SK; Reveille JD; Arnett FC; Wigley FM; Assassi S Ann Rheum Dis; 2012 Jul; 71(7):1197-202. PubMed ID: 22440820 [TBL] [Abstract][Full Text] [Related]
7. [The influence of STAT4 rs7574865 (G/T) polymorphism on the risk of clinical and immunological phenotypes of systemic sclerosis in a Russian patient population: Results of a pilot study]. Krylov MY; Ananyeva LP; Koneva ОА; Starovoytova MN; Desinova OV; Ovsyannikova OB; Aleksandrova EN; Novikov AA; Guseva IA; Konovalova NV; Varlamov DA Ter Arkh; 2017; 89(5):20-25. PubMed ID: 28631694 [TBL] [Abstract][Full Text] [Related]
9. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population. Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858 [TBL] [Abstract][Full Text] [Related]
10. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Abelson AK; Delgado-Vega AM; Kozyrev SV; Sánchez E; Velázquez-Cruz R; Eriksson N; Wojcik J; Linga Reddy MV; Lima G; D'Alfonso S; Migliaresi S; Baca V; Orozco L; Witte T; Ortego-Centeno N; ; Abderrahim H; Pons-Estel BA; Gutiérrez C; Suárez A; González-Escribano MF; Martin J; Alarcón-Riquelme ME Ann Rheum Dis; 2009 Nov; 68(11):1746-53. PubMed ID: 19019891 [TBL] [Abstract][Full Text] [Related]
11. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Dieudé P; Guedj M; Wipff J; Avouac J; Fajardy I; Diot E; Granel B; Sibilia J; Cabane J; Mouthon L; Cracowski JL; Carpentier PH; Hachulla E; Meyer O; Kahan A; Boileau C; Allanore Y Arthritis Rheum; 2009 Jan; 60(1):225-33. PubMed ID: 19116937 [TBL] [Abstract][Full Text] [Related]
12. Gene-gene interactions of IRF5, STAT4, IKZF1 and ETS1 in systemic lupus erythematosus. Dang J; Shan S; Li J; Zhao H; Xin Q; Liu Y; Bian X; Liu Q Tissue Antigens; 2014 Jun; 83(6):401-8. PubMed ID: 24697319 [TBL] [Abstract][Full Text] [Related]
13. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity. Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Systemic Sclerosis-associated Genes in a Turkish Population. Carmona FD; Onat AM; Fernández-Aranguren T; Serrano-Fernández A; Robledo G; Direskeneli H; Sawalha AH; Yavuz S; Martín J J Rheumatol; 2016 Jul; 43(7):1376-9. PubMed ID: 27134258 [TBL] [Abstract][Full Text] [Related]
15. Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese. Wang J; Yi L; Guo X; Liu M; Li H; Zou H; Gu Y; Tu W; Guo G; Yang L; Lai S; He D; Zhou X Int J Immunopathol Pharmacol; 2014; 27(4):635-8. PubMed ID: 25572744 [TBL] [Abstract][Full Text] [Related]
16. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Rueda B; Broen J; Simeon C; Hesselstrand R; Diaz B; Suárez H; Ortego-Centeno N; Riemekasten G; Fonollosa V; Vonk MC; van den Hoogen FH; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Coenen MJ; Airo P; Beretta L; Scorza R; van Laar J; Gonzalez-Escribano MF; Nelson JL; Radstake TR; Martin J Hum Mol Genet; 2009 Jun; 18(11):2071-7. PubMed ID: 19286670 [TBL] [Abstract][Full Text] [Related]
17. STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population. Yi L; Wang JC; Guo XJ; Gu YH; Tu WZ; Guo G; Yang L; Xiao R; Yu L; Mayes MD; Assassi S; Jin L; Zou HJ; Zhou XD Int J Immunopathol Pharmacol; 2013; 26(2):473-478. PubMed ID: 23755762 [TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines. Gourh P; Agarwal SK; Divecha D; Assassi S; Paz G; Arora-Singh RK; Reveille JD; Shete S; Mayes MD; Arnett FC; Tan FK Arthritis Rheum; 2009 Dec; 60(12):3794-806. PubMed ID: 19950257 [TBL] [Abstract][Full Text] [Related]
19. Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease. Odani T; Yasuda S; Ota Y; Fujieda Y; Kon Y; Horita T; Kawaguchi Y; Atsumi T; Yamanaka H; Koike T Rheumatology (Oxford); 2012 Oct; 51(10):1765-74. PubMed ID: 22723597 [TBL] [Abstract][Full Text] [Related]
20. Unfolding the pathogenesis of scleroderma through genomics and epigenomics. Tsou PS; Sawalha AH J Autoimmun; 2017 Sep; 83():73-94. PubMed ID: 28526340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]